|
|
 |
| |
|
Posted by admin on Thursday, December 03 @ 23:08:39 EST (566 reads)
(Read More... | Score: 2)
|
|
 | Hidden help: the good news story you never heard |
 Hidden help: the good news story you never heard
By Sabra Lane - analysis
Click here to see article
Something of a minor miracle happened last weekend. The Federal Government announced funding of more than $1.13m for a research alliance, and it didn't make the news.
Big deal? It is a big deal and we should be shouting it from the rooftops, because it could quite literally save thousands of lives, help many infertile women have families and stop their siblings and parents from developing a serious health condition.
|
|
|
Posted by charmaine on Tuesday, September 15 @ 11:24:12 EST (866 reads)
(Read More... | 6592 bytes more | Score: 5)
|
|
|
| : IVF - Future risks to children |
cranky cyster writes "Interesting article in the UK Times about the children born from IVF -- and how they can inherit the same fertility problems.
"
|
|
|
Posted by charmaine on Saturday, February 16 @ 12:43:58 EST (2332 reads)
(Read More... | 242 bytes more | | Score: 0)
|
|
|
| : News item: Obesity epidemic may make more women infertile |
I have included the full article from the Sydney Morning Herald, August 25, 2007 in the extended text.
This is the summary from Lancet Medical Journal:
Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide.
Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide.
The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity.
Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome.
Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease.
The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features.
A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial.
The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.
-------------------------------
|
|
|
Posted by Sabra on Saturday, August 25 @ 09:23:01 EST (2551 reads)
(Read More... | 4289 bytes more | | Score: 5)
|
|
|
| Fertility drugs low cancer risk: report |
cranky cyster writes "Thought I would post this news article, published in today's Age Newspaper (August 13, 2007) - about cancer rates and fertility treatment.
--------------------------------------
Drugs used to treat female infertility do not appear to be associated with an increased risk of breast cancer, according to a new report.
Based on these findings and others, "infertile women should not worry about breast cancer," Dr Allan Jensen from the Danish Cancer Society, Copenhagen, told Reuters Health.
Jensen and his associates evaluated the effects of different types of fertility drugs on the risk of breast cancer, after taking account of reproductive factors that are known to affect the risk, in a study involving more than 54,000 women with infertility problems.
Out of that whole group, 331 women developed breast cancer after an average of 14 years, the investigators report in the journal Cancer Epidemiology, Biomarkers, and Prevention.
After adjustment, the researchers found that clomiphene and four synthetic hormones used to boost fertility did not significantly affect the risk of breast cancer.
The use of progesterone was associated with an increased risk of subsequent breast cancer, the investigators say, but this increased risk was based on only eight cases.
"The progesterone results are limited by a low number of cases," Jensen said. "We will therefore increase the follow-up period in order to collect more cases. Also, as progesterone is mainly used for IVF patients, we will go into more details with this subgroup."
In any case, he added, "we are talking about small increased relative risks, and therefore the absolute risk will still be low."
"
|
|
|
Posted by Sabra on Monday, August 13 @ 22:51:08 EST (2105 reads)
(Read More... | 1927 bytes more | Score: 3)
|
|
| |
|
|
| |
